小鼠胰腺癌肝转移模型及相关分子表达的研究(4)

[3] Schmittgen quantitative PCR[J].Methods,2001,25(4):383-385.

[4] Ponehel F,Toomes C,Bransfield K,et PCR based on SYBR Green I fluorescence:an alternative to the Taqman assay for a relative quantification of gene rearrangements,gene amplifications and micro sane deletions[J].BMC Biotechnol,2003,13；3:18.

[5] Xie K,Huang S,Dong Z,et correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP[J].Cancer Res,1995,55(14):3123-3131.

[6] Kopper L,Van Hanh T,Lapis model for liver metastasis formation using Lewis lung tumor[J].J Cancer Res Clin Oncol,1982,103(1):31-38.

[7] Moreno JA,Sanchez A,Hoffman RM,et Orthotopic Mouse Model of Pancreatic Cancer[J].J Vis Exp,2016,20:115.

[8] Mahipal A,Frakes J,Hoffe S,et of borderline resectable pancreatic cancer[J].World J Gastrointest Oncol,2015,7(10):241-249.

[9] De La,Cruz MS,Young AP,Ruffin and management of pancreatic cancer[J].Am Fam Physician,2014,89(8):626-632.

[10] Fidler factors in the biology of human cancer metastasis:twenty-eighth memorial award lecture[J].Cancer Res,1990,50(19):6130-6138.

[11] Sugarbaker metastasis:a product of tumor-host interactions[J].Curr Probl Cancer,1979,3(7):1-59.

[12] Xie K,Huang of cancer metastasis by stress pathways[J].Clinical Expl Metastasis,2003,20(1):31-43.

[13] Beenken A,Mohammadi M.The FGF family:biology,pathophysiology and therapy[J].Nat Rev Drug Discov,2009,8(3):235-253.

[14] Guo B,Zhai D,Cabezas E,et peptide suppresses apoptosis by interfering with Bax activation[J].Nature,2003,423(6938):456-461.

[15] Chittenden T,Harrington EA,O'Connor R,et of apoptosis by the Bcl-2 homologue Bak[J].Nature,1995,374(6524):733-736.

[16] Zhang JJ,Zhu Y,Yang C,et al.Yin Yang-1 increases apoptosis through Bax activation in pancreatic cancer cells[J].Oncotarget,2016,7(19):-.

[17] Akhurst RJ,Derynck signaling in cancer-a double-edged sword[J].Trends Cell Biol,2001,11(11):S44-51

[18] Folkman J.Tumor angiogenesis and tissue factor[J].Nat Med,1996,2(2):167-168

[19] Leek RD,Harris AL,Lewis networks in solid human tumors:regulation of angiogenesis[J].J Leukoc Biol,1994,56(4):423-435

[20] Itakura J,Ishiwata T,Friess H,et expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression[J].Clin Cancer Res,1997,3(8):1309-1316

[21] Yamanaka Y,Friess H,Buchler M,et of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage[J].Cancer Res,1993,53(21):5289-5296

[22] Xie and Human Cancer Biology[J].Cytokine Growth Factor Rew,2001,12(4):375-391

[23] Moawad effectiveness of imatinib mesylate in tumors expressing platelet-derived growth factors(PDGF-AA,PDGF-BB),Stem cell factor ligands and their respective receptors(PDGFR-α,PDGFR-β,and c-kit)[J].J Gastrointest Cancer,2015,46(3):272-283.

[24] Zhang ZX,Zhou J,Zhang Y,et of angiopoietin-2 suppresses metastasis in human pancreatic carcinoma by reduced matrix metalloproteinase-2[J].Mol Biotechnol,2013,53(3):336-344.

[25] Hage B,Meinel K,Baum I.Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells[J].Cell Commun Signal,2009,7:23.

[26] Desgrosellier JS,Cheresh in cancer:biological implications and therapeutic opportunities[J].Nat Rev Cancer,2010,10(1):9-22.

[27] Kessenbrock K,Plaks V,Werb Z.Matrix metalloproteinases:regulators of the tumor microenvironment[J].Cell,2010,141(1):52-67.

[28] Roomi MW,Kalinovsky T,Niedzwiecki A,et of uPA,MMPs and their inhibitors by a novel nutrient mixture in human colorectal,pancreatic and hepatic carcinoma cell lines[J].Int J Oncol,2015,47(1):370-376.

[29] Kufareva I,Salanga CL,Handel and chemokine receptor structure and interactions:Implications for therapeutic strategies[J].Immunol Cell Biol,2015,93(4):372-383.

[30] Roy I,Getschman AE,Volkman BF,et agonist biased signaling of chemokines to target cancer[J].Mol Carcinog,2017,56(3):804-813.

[31] Nicolson metastasis:tumor cell and host organ properties important in metastasis to specific secondary sites[J].Biochim Biophys Acta,1988,948(2):175-208

[32] Dittmar T,Heyder C,Gloria-Maercker E,et molecules and chemokines:the navigation system for circulating tumor(stem)cells to metastasize in an organ-specific manner[J].Clin Exp Metastasis,2008,25(1):11-32

[33] Radinsky of tumor cell gene expression and phenotype by the organ-specific metastatic environment[J].Cancer Metastasis Rev,1995,14(4):323-338

[34] Zhong Y,Macgregor-Das AM,Saunders T,et p53 together with TGF-β signaling influence organ-specific hematogenous colonization patterns of pancreatic cancer[J].Clin Cancer Res,2017,23(6): Sep 16.

[35] Maehara N,Matsumoto K,Kuba K,et al.NK4,a four-kringle antagonist of HGF,inhibits spreading and invasion of human pancreatic cancer cells[J].Br J Cancer,2001,84(6):864-873.

文章来源：《分子科学学报》 网址: http://www.fzkxxbzz.cn/qikandaodu/2020/1215/459.html